High-efficiency lysis of cervical cancer by allogeneic NK cells derived from umbilical cord progenitors is independent of HLA status
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High-efficiency lysis of cervical cancer by allogeneic NK cells derived from umbilical cord progenitors is independent of HLA status
Authors
Keywords
Cervical cancer, Peripheral blood NK cells, Umbilical cord blood stem cell-derived NK cells, CET, NK ligands and receptors, Adoptive NK immunotherapy
Journal
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume 66, Issue 1, Pages 51-61
Publisher
Springer Nature
Online
2016-10-25
DOI
10.1007/s00262-016-1919-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Role of NKG2D, DNAM-1 and natural cytotoxicity receptors in cytotoxicity toward rhabdomyosarcoma cell lines mediated by resting and IL-15-activated human natural killer cells
- (2015) Gerharda H. Boerman et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Immunotherapy and targeted therapy for cervical cancer: an update
- (2015) Gulden Menderes et al. Expert Review of Anticancer Therapy
- Complete Regression of Metastatic Cervical Cancer After Treatment With Human Papillomavirus–Targeted Tumor-Infiltrating T Cells
- (2015) Sanja Stevanović et al. JOURNAL OF CLINICAL ONCOLOGY
- The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer
- (2015) Katayoun Rezvani et al. Frontiers in Immunology
- MICA/B and ULBP1 NKG2D ligands are independent predictors of good prognosis in cervical cancer
- (2015) Hanbyoul Cho et al. BMC CANCER
- Effect of tumor cells and tumor microenvironment on NK-cell function
- (2014) Massimo Vitale et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Current advances in T-cell-based cancer immunotherapy
- (2014) Mingjun Wang et al. Immunotherapy
- NKp44L
- (2014) Vincent Vieillard et al. OncoImmunology
- NK cell-based immunotherapy for malignant diseases
- (2013) Min Cheng et al. Cellular & Molecular Immunology
- Natural killer cell biology: An update and future directions
- (2013) Kerry S. Campbell et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Natural Killer Cells Generated from Cord Blood Hematopoietic Progenitor Cells Efficiently Target Bone Marrow-Residing Human Leukemia Cells in NOD/SCID/IL2Rgnull Mice
- (2013) Jeannette Cany et al. PLoS One
- Natural Killer Cell Mediated Antibody-Dependent Cellular Cytotoxicity in Tumor Immunotherapy with Therapeutic Antibodies
- (2013) Ursula J. E. Seidel et al. Frontiers in Immunology
- Cervical cancer cell lines expressing NKG2D-ligands are able to down-modulate the NKG2D receptor on NKL cells with functional implications
- (2012) Miriam I. Jimenez-Perez et al. BMC IMMUNOLOGY
- Treatment of metastatic cervical cancer: Future directions involving targeted agents
- (2012) Ivan Diaz-Padilla et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Molecularly targeted therapies in cervical cancer. A systematic review
- (2012) Flora Zagouri et al. GYNECOLOGIC ONCOLOGY
- KRAS and BRAF Mutation Analysis in Routine Molecular Diagnostics
- (2012) Daniëlle A.M. Heideman et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- HLA-E expression in cervical adenocarcinomas: association with improved long-term survival
- (2012) Vivian M Spaans et al. Journal of Translational Medicine
- Ex Vivo Generated Natural Killer Cells Acquire Typical Natural Killer Receptors and Display a Cytotoxic Gene Expression Profile Similar to Peripheral Blood Natural Killer Cells
- (2012) Dorit Lehmann et al. STEM CELLS AND DEVELOPMENT
- Human papillomavirus entry into NK cells requires CD16 expression and triggers cytotoxic activity and cytokine secretion
- (2011) Virginie M. Renoux et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Phase II study of cisplatin plus cetuximab in advanced, recurrent, and previously treated cancers of the cervix and evaluation of epidermal growth factor receptor immunohistochemical expression: A Gynecologic Oncology Group study
- (2011) John Farley et al. GYNECOLOGIC ONCOLOGY
- Use of allogeneic NK cells for cancer immunotherapy
- (2011) Melissa A Geller et al. Immunotherapy
- Molecular mechanisms of epidermal growth factor receptor overexpression in patients with cervical cancer
- (2011) Marlies Schrevel et al. MODERN PATHOLOGY
- Clinical-Grade Generation of Active NK Cells from Cord Blood Hematopoietic Progenitor Cells for Immunotherapy Using a Closed-System Culture Process
- (2011) Jan Spanholtz et al. PLoS One
- HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8+ T lymphocytes
- (2011) M. Gooden et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cetuximab monotherapy in advanced cervical cancer: a retrospective study with five patients
- (2010) Linda Hertlein et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer
- (2010) Melissa A. Geller et al. CYTOTHERAPY
- Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
- (2010) Wendy De Roock et al. LANCET ONCOLOGY
- High Log-Scale Expansion of Functional Human Natural Killer Cells from Umbilical Cord Blood CD34-Positive Cells for Adoptive Cancer Immunotherapy
- (2010) Jan Spanholtz et al. PLoS One
- Low NKp30, NKp46 and NKG2D expression and reduced cytotoxic activity on NK cells in cervical cancer and precursor lesions
- (2009) Trinidad Garcia-Iglesias et al. BMC CANCER
- Combination of cetuximab with chemoradiation, trastuzumab or MAPK inhibitors: mechanisms of sensitisation of cervical cancer cells
- (2009) D D Meira et al. BRITISH JOURNAL OF CANCER
- Augmented serum level of major histocompatibility complex class I-related chain A (MICA) protein and reduced NKG2D expression on NK and T cells in patients with cervical cancer and precursor lesions
- (2008) Naela A Arreygue-Garcia et al. BMC CANCER
- Human Leukocyte Antigen Class I, MHC Class I Chain-Related Molecule A, and CD8+/Regulatory T-Cell Ratio: Which Variable Determines Survival of Cervical Cancer Patients?
- (2008) E. S. Jordanova et al. CLINICAL CANCER RESEARCH
- Classical and non-classical HLA molecules and p16INK4a expression in precursors lesions and invasive cervical cancer
- (2008) Maria Alice G. Gonçalves et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- Activating NK cell receptor ligands are differentially expressed during progression to cervical cancer
- (2008) Sonja Textor et al. INTERNATIONAL JOURNAL OF CANCER
- Functions of natural killer cells
- (2008) Eric Vivier et al. NATURE IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started